# Glycine Treatment of Prodromal Symptoms

> **NCT00268749** · PHASE2 · COMPLETED · sponsor: **Yale University** · enrollment: 10 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** glycine

## Key facts

- **NCT ID:** NCT00268749
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-07
- **Primary completion:** 2004-11
- **Final completion:** 2004-11
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2012-03-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00268749

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00268749, "Glycine Treatment of Prodromal Symptoms". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00268749. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*